U.S. Food and Drug Administration authorized the first diagnostic test with the option of using home-collected saliva samples for COVID-19 testing. Specifically, the FDA issued an emergency use authorization (EUA) to Rutgers Clinical Genomics Laboratory for their COVID-19 laboratory developed test (LDT), which had been previously added to the high complexity molecular-based LDT “umbrella” EUA, to permit testing of samples self-collected by patients at home using the Spectrum Solutions LLC SDNA-1000 Saliva Collection Device. This announcement builds on last month’s EUA for the first diagnostic test with a home-collection option, which uses a sample collected from the patient’s nose with a nasal swab and saline.

U.S. Food and Drug Administration approved Retevmo (selpercatinib) capsules to treat three types of tumors – non-small cell lung cancer, medullary thyroid cancer and other types of thyroid cancers – in patients whose tumors have an alteration (mutation or fusion) in a specific gene (RET or “rearranged during transfection”). Retevmo is the first therapy approved specifically for cancer patients with the RET gene alterations.

U.S. Food and Drug Administration is providing an update on the agency’s efforts to combat the extremely concerning actions by companies and individuals that are exploiting or taking advantage of widespread fear among consumers during the COVID-19 pandemic. In response to scammers on the internet selling unproven medical products, the FDA has taken – and continues to take – a number of steps to find and stop those selling unapproved products that fraudulently claim to mitigate, prevent, treat, diagnose or cure COVID-19.

U.S. Food and Drug Administration approved Tabrecta (capmatinib) for the treatment of adult patients with non-small cell lung cancer (NSCLC) that has spread to other parts of the body. Tabrecta is the first FDA-approved therapy to treat NSCLC with specific mutations (those that lead to mesenchymal-epithelial transition or MET exon 14 skipping).

12 May 2020
Pharma Research Job at Tata Medical Center

The Tata Medical Center (TMC) is a multispecialty institution for tertiary cancer care based in New Town, Kolkata. At TMC, clinical and research activities are integrated to provide state-of-the-art care for patients with cancer. This integration is enabled by the Tata Translational Cancer Research Centre (TTCRC), the research arm of TMC. TTCRC is within a dedicated academic space and spread over 3 floors. At TTCRC, a multidisciplinary team of clinicians, scientists, academics and industry professionals collaborate to develop a systems medicine approach in cancer research.

Post : Postdoctoral Fellow

12 May 2020
Applications are invited for Project Scientist, Research Assistant at PGIMER

The PGIMER owes its inception to the vision of late Sardar Partap Singh Kairon, the then Chief Minister of Punjab and the distinguished medical educationists of the then combined state of Punjab, supported by the first Prime Minister of India Pt. Jawahar Lal Nehru who considered the institutions of scientific knowledge as temples of learning and the places of pilgrimage. The institute started in 1962 and Pt Jawahar Lal Nehru inaugurated the hospital now named “Nehru Hospital” on 7th July 1963.

12 May 2020
Multiple Job Openings at Gracure Pharmaceuticals Limited | M.Sc, M.Pharm, B.Pharm

Gracure Pharmaceutical Ltd. is a Delhi based pharmaceutical company, established in 1992 by Mr. A.S Bhargava with the vision of making world class affordable medicines. Gracure is a research driven forward looking pharmaceutical company with expertise in development of various finished dosage. Gracure R&D and EU-GMP approved Manufacturing Unit is located in Bhiwadi, Rajasthan.

12 May 2020
Pharma Clinical Research job at WNS Limited | 90 posts

WNS (Holdings) Limited is a leading Business Process Management (BPM) company. We combine our deep industry knowledge with technology and analytics expertise to co-create innovative, digital-led transformational solutions with clients across 10 industries. We enable businesses in Travel, Insurance, Banking and Financial Services, Manufacturing, Retail and Consumer Packaged Goods, Shipping and Logistics, Healthcare, and Utilities to re-imagine their digital future and transform their outcomes with operational excellence.

Post : Pharma Clinical Research - 90 posts

12 May 2020
Job for Assistant professor at Karavali College of Pharmacy

12 May 2020
Openings for B.Pharm, M.Sc Freshers & Experienced at Pulse Pharmaceuticals

Pulse is a fast-growing Pharmaceutical company with a vertically & diagonally integrated business model, focused on providing innovative product solutions to a large number of people around the world, to help them manage their health better & lead a quality life.

12 May 2020
Vacancy for M.Pharm, M.Sc, B.Pharm in Quality Control at Mankind Pharma | 15 posts

Mankind Pharma, the 7th largest Pharmaceutical Company of India, was incepted in 1995 with a meagre capital of 50 lakhs and 20 employees. Today, we are amongst the top 5 fastest growing Pharmaceutical companies of India with an employee base of more than 10000 and heading towards a turnover of  INR 3000 crores.

Post : Officer/Senior Officer

12 May 2020
AstraZeneca looking for Key Accounts Manager | B.Pharm, B.Sc

AstraZeneca is an exciting global, innovation-driven biopharmaceutical company. We’re inspired by what science can do. Driven by the desire to meet unmet patient needs in our core therapeutic areas. Bold in our thinking. Proactive in pursuing discoveries beyond imagination. At sites across the world, we bring teams together in a spirit of collaboration to turn great ideas into life-changing medicines – strengthening our product portfolio and harnessing the potential of a pipeline across all stages of the drug development process.

Post : Key Accounts Manager - Fasenra

12 May 2020
Work as Senior Director in Distribution, Supply & Patient Solutions at Gilead Sciences

Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercialises innovative medicines in areas of unmet medical need. With each new discovery and investigational drug candidate, we seek to improve the care of patients living with life-threatening diseases around the world. Gilead’s therapeutic areas of focus include HIV/AIDS, liver diseases, cancer and inflammation, and serious respiratory and cardiovascular conditions.

Post : Senior Director, Distribution, Supply & Patient Solutions, Asia Pacific

12 May 2020
Require Manager in CMC Renewals at GSK Rx India

GlaxoSmithKline Pharmaceuticals Ltd. (GSK Rx India) is one of the oldest pharmaceuticals company and employs over 5000+ people. Globally, we are a £ 27.4 billion, leading, research-based healthcare and pharmaceutical company. In India, we are one of the market leaders.

Post : Manager – CMC Renewals

12 May 2020
Opportunity to work as Deputy Regional Director at IAVI

IAVI is a nonprofit scientific research organization dedicated to addressing urgent, unmet global health challenges including HIV and tuberculosis. Our mission is to translate scientific discoveries into affordable, globally accessible public health solutions.  Through scientific and clinical research in Africa, India, Europe, and the U.S., IAVI is pioneering the development of biomedical innovations designed for broad global access. We develop vaccines and antibodies in and for the developing world and seek to accelerate their introduction in low-income countries.

Post : Deputy Regional Director India

Glenmark Pharmaceuticals, a research-led, integrated global pharmaceutical company has initiated Phase 3 clinical trials in India on Antiviral tablet Favipiravir, for which it received approval from India’s drug regulator DCGI in late April. Glenmark is the first company in India to initiate Phase 3 clinical trials on Favipiravir for COVID-19 patients in India. Favipiravir is a generic version of Avigan® of Fujifilm Toyama Chemical Co. Ltd., Japan, a subsidiary of Fujifilm Corporation. Clinical trials have commenced and over 10 leading government & private hospitals in India are being enrolled for the study. Glenmark estimates study completion by July/August 2020.

Glenmark Pharmaceuticals Ltd. (Glenmark), a research-led global integrated pharmaceutical company, today announced the launch of a Single Inhaler Triple Therapy AIRZ-FF - a combination of two bronchodilators, Glycopyrronium & Formoterol and the inhalation corticosteroid Fluticasone propionate, for Chronic Obstructive Pulmonary Disease (COPD).

12 May 2020
WOMEN EMPOWERMENT AND ITS IMPACT IN PHARMA WORLD

The live interaction session on theme Women empowerment and its impact in pharma world was organized on 25th April, 2020, 04:00 PM to 5:30 PM. The live session was convened by Dr. Neelesh Malviya, Professor and Principal, Smriti College of Pharmaceutical Education, Indore, introduced by Dr. Sapna Malviya, Department of Pharm. Science, Modern Institute of Pharmaceutical Sciences, Indore. The Invited women experts were Prof. Dr. Swarnlata Saraf, Professor, University Institute of Pharmacy, Pt. Ravi Shankar Shukla University, Raipur, Chhattisgarh, Prof. Dr. Sanju Nanda, Head, Department of Pharm. Science, MD University, Rohtak Haryana, Ms. Manjari Ghart, Vice President, Indian Pharmaceutical Association, Vice President, CPS section, FIP, Incharge Principal, PKM Kundanani Pharmacy, Polytechnic Ulhasnagar, Mumbai.

12 May 2020
MODERN ERA OF PHARMACEUTICAL EDUCATION IN INDIA

The live interaction session with Prof. Dr. Shailendra Saraf Sir on the theme Modern Era of Pharmaceutical Education in India was organized on 30th April, 2020, 05:00 PM to 6:00 PM.

The Session was successfully convened by Dr. Neelesh Malviya, Principal and Professor, Smriti College of Pharmaceutical Education, Indore. He has outlined the concept of the Live Interaction on burgeoning issues of significant role of Pharmacy Professionals in Health care team and current Initiative of Pharmacy Council of India for upliftment of Pharmacy Profession and Professionals.

Subscribe to